EMEA (Europe, Middle East and Africa) Pediatric Drugs and Vaccines Market Report 2017

October 2017 | 119 pages | ID: EAF08EA2330PEN
QYResearch

Abstracts

In this report, the EMEA Pediatric Drugs and Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
%li%Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Pediatric Drugs and Vaccines for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pediatric Drugs and Vaccines market competition by top manufacturers/players, with Pediatric Drugs and Vaccines sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck & Co., Inc. (USA)
• Abbott Laboratories (USA)
• Amgen, Inc. (USA)
• Eli Lilly and Company (USA)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Genentech, Inc. (USA)
• GlaxoSmithKline plc. (UK)
• Janssen Biologics B.V. (USA)
• Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
• AstraZeneca Plc. (UK)
• Boehringer Ingelheim GmbH (Germany)
• Bristol-Myers Squibb Company (USA)
• Allergan, Inc. (USA)
• Novartis AG (Switzerland)
• Novo Nordisk A/S (Denmark)
• Pfizer, Inc. (USA)
• Sanofi S.A (France)
• Shionogi Inc. (USA)
• Shire Pharmaceuticals Group Plc. (UK)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• by Vaccine Types
• Diphtheria
• Influenza
• Hepatitis
• Pneumococcal Diseases
• Meningococcal Diseases
• Mumps
• Others
• by Disease Types
• Roseola
• Tetanus
• Whooping Cough
• Allergy and Respiratory Diseases
• Malaria
• Anemia
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Pediatric Drugs and Vaccines for each application, including

• Newborn
• Infant
• Child

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pediatric Drugs and Vaccines Market Report 2017

1 PEDIATRIC DRUGS AND VACCINES OVERVIEW

1.1 Product Overview and Scope of Pediatric Drugs and Vaccines
1.2 Classification of Pediatric Drugs and Vaccines
  1.2.1 EMEA Pediatric Drugs and Vaccines Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Pediatric Drugs and Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Diphtheria
  1.2.4 Influenza
  1.2.5 Hepatitis
  1.2.6 Pneumococcal Diseases
  1.2.7 Meningococcal Diseases
  1.2.8 Mumps
  1.2.9 Others
1.3 EMEA Pediatric Drugs and Vaccines Market by Application/End Users
  1.3.1 EMEA Pediatric Drugs and Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Newborn
  1.3.3 Infant
  1.3.4 Child
1.4 EMEA Pediatric Drugs and Vaccines Market by Region
  1.4.1 EMEA Pediatric Drugs and Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Pediatric Drugs and Vaccines (2012-2022)
  1.5.1 EMEA Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Pediatric Drugs and Vaccines Revenue and Growth Rate (2012-2022)

2 EMEA PEDIATRIC DRUGS AND VACCINES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pediatric Drugs and Vaccines Market Competition by Players/Manufacturers
  2.1.1 EMEA Pediatric Drugs and Vaccines Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Pediatric Drugs and Vaccines Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Pediatric Drugs and Vaccines Sale Price by Players (2012-2017)
2.2 EMEA Pediatric Drugs and Vaccines (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pediatric Drugs and Vaccines Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Pediatric Drugs and Vaccines Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Pediatric Drugs and Vaccines Sale Price by Type (2012-2017)
2.3 EMEA Pediatric Drugs and Vaccines (Volume) by Application
2.4 EMEA Pediatric Drugs and Vaccines (Volume and Value) by Region
  2.4.1 EMEA Pediatric Drugs and Vaccines Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Pediatric Drugs and Vaccines Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Pediatric Drugs and Vaccines Sales Price by Region (2012-2017)

3 EUROPE PEDIATRIC DRUGS AND VACCINES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pediatric Drugs and Vaccines Sales and Value (2012-2017)
  3.1.1 Europe Pediatric Drugs and Vaccines Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Pediatric Drugs and Vaccines Revenue and Growth Rate (2012-2017)
3.2 Europe Pediatric Drugs and Vaccines Sales and Market Share by Type
3.3 Europe Pediatric Drugs and Vaccines Sales and Market Share by Application
3.4 Europe Pediatric Drugs and Vaccines Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pediatric Drugs and Vaccines Sales Volume by Countries (2012-2017)
  3.4.2 Europe Pediatric Drugs and Vaccines Revenue by Countries (2012-2017)
  3.4.3 Germany Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  3.4.4 France Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  3.4.5 UK Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  3.4.6 Russia Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  3.4.7 Italy Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PEDIATRIC DRUGS AND VACCINES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pediatric Drugs and Vaccines Sales and Value (2012-2017)
  4.1.1 Middle East Pediatric Drugs and Vaccines Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Pediatric Drugs and Vaccines Revenue and Growth Rate (2012-2017)
4.2 Middle East Pediatric Drugs and Vaccines Sales and Market Share by Type
4.3 Middle East Pediatric Drugs and Vaccines Sales and Market Share by Application
4.4 Middle East Pediatric Drugs and Vaccines Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pediatric Drugs and Vaccines Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Pediatric Drugs and Vaccines Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  4.4.4 Israel Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  4.4.5 UAE Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  4.4.6 Iran Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)

5 AFRICA PEDIATRIC DRUGS AND VACCINES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pediatric Drugs and Vaccines Sales and Value (2012-2017)
  5.1.1 Africa Pediatric Drugs and Vaccines Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Pediatric Drugs and Vaccines Revenue and Growth Rate (2012-2017)
5.2 Africa Pediatric Drugs and Vaccines Sales and Market Share by Type
5.3 Africa Pediatric Drugs and Vaccines Sales and Market Share by Application
5.4 Africa Pediatric Drugs and Vaccines Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pediatric Drugs and Vaccines Sales Volume by Countries (2012-2017)
  5.4.2 Africa Pediatric Drugs and Vaccines Revenue by Countries (2012-2017)
  5.4.3 South Africa Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Pediatric Drugs and Vaccines Sales and Growth Rate (2012-2017)

6 EMEA PEDIATRIC DRUGS AND VACCINES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc. (USA)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories (USA)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Amgen, Inc. (USA)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly and Company (USA)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd (Switzerland)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Genentech, Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GlaxoSmithKline plc. (UK)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Janssen Biologics B.V. (USA)
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca Plc. (UK)
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Pediatric Drugs and Vaccines Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim GmbH (Germany)
6.12 Bristol-Myers Squibb Company (USA)
6.13 Allergan, Inc. (USA)
6.14 Novartis AG (Switzerland)
6.15 Novo Nordisk A/S (Denmark)
6.16 Pfizer, Inc. (USA)
6.17 Sanofi S.A (France)
6.18 Shionogi Inc. (USA)
6.19 Shire Pharmaceuticals Group Plc. (UK)

7 PEDIATRIC DRUGS AND VACCINES MANUFACTURING COST ANALYSIS

7.1 Pediatric Drugs and Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pediatric Drugs and Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pediatric Drugs and Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PEDIATRIC DRUGS AND VACCINES MARKET FORECAST (2017-2022)

11.1 EMEA Pediatric Drugs and Vaccines Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Pediatric Drugs and Vaccines Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Pediatric Drugs and Vaccines Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Pediatric Drugs and Vaccines Price and Trend Forecast (2017-2022)
11.2 EMEA Pediatric Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Pediatric Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Pediatric Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Pediatric Drugs and Vaccines Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Pediatric Drugs and Vaccines Sales Forecast by Type (2017-2022)
11.7 EMEA Pediatric Drugs and Vaccines Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pediatric Drugs and Vaccines
Figure EMEA Pediatric Drugs and Vaccines Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Pediatric Drugs and Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Diphtheria Product Picture
Figure Influenza Product Picture
Figure Hepatitis Product Picture
Figure Pneumococcal Diseases Product Picture
Figure Meningococcal Diseases Product Picture
Figure Mumps Product Picture
Figure Others Product Picture
Figure EMEA Pediatric Drugs and Vaccines Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Pediatric Drugs and Vaccines by Application in 2016
Figure Newborn Examples
Table Key Downstream Customer in Newborn
Figure Infant Examples
Table Key Downstream Customer in Infant
Figure Child Examples
Table Key Downstream Customer in Child
Figure EMEA Pediatric Drugs and Vaccines Market Size (Million USD) by Region (2012-2022)
Figure Europe Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pediatric Drugs and Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Pediatric Drugs and Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Pediatric Drugs and Vaccines Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pediatric Drugs and Vaccines Sales Volume and Growth Rate (2012-2022)
Figure EMEA Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Pediatric Drugs and Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Sales Share by Players (2012-2017)
Figure 2016 Pediatric Drugs and Vaccines Sales Share by Players
Figure 2017 Pediatric Drugs and Vaccines Sales Share by Players
Figure EMEA Pediatric Drugs and Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Revenue (Million USD) by Players (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Revenue Share by Players (2012-2017)
Table 2016 EMEA Pediatric Drugs and Vaccines Revenue Share by Players
Table 2017 EMEA Pediatric Drugs and Vaccines Revenue Share by Players
Table EMEA Pediatric Drugs and Vaccines Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Sales Share by Type (2012-2017)
Figure Sales Market Share of Pediatric Drugs and Vaccines by Type (2012-2017)
Figure EMEA Pediatric Drugs and Vaccines Sales Market Share by Type (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pediatric Drugs and Vaccines by Type in 2016
Table EMEA Pediatric Drugs and Vaccines Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Sales Share by Application (2012-2017)
Figure Sales Market Share of Pediatric Drugs and Vaccines by Application (2012-2017)
Figure EMEA Pediatric Drugs and Vaccines Sales Market Share by Application in 2016
Table EMEA Pediatric Drugs and Vaccines Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Sales Share by Region (2012-2017)
Figure Sales Market Share of Pediatric Drugs and Vaccines by Region (2012-2017)
Figure EMEA Pediatric Drugs and Vaccines Sales Market Share in 2016
Table EMEA Pediatric Drugs and Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Pediatric Drugs and Vaccines Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Pediatric Drugs and Vaccines by Region (2012-2017)
Figure EMEA Pediatric Drugs and Vaccines Revenue Market Share Regions in 2016
Table EMEA Pediatric Drugs and Vaccines Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Revenue and Growth Rate (2012-2017)
Table Europe Pediatric Drugs and Vaccines Sales (K Units) by Type (2012-2017)
Table Europe Pediatric Drugs and Vaccines Market Share by Type (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Market Share by Type in 2016
Table Europe Pediatric Drugs and Vaccines Sales (K Units) by Application (2012-2017)
Table Europe Pediatric Drugs and Vaccines Market Share by Application (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Market Share by Application in 2016
Table Europe Pediatric Drugs and Vaccines Sales (K Units) by Countries (2012-2017)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Sales Market Share by Countries in 2016
Table Europe Pediatric Drugs and Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Europe Pediatric Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Europe Pediatric Drugs and Vaccines Revenue Market Share by Countries in 2016
Figure Germany Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure France Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UK Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Pediatric Drugs and Vaccines Sales (K Units) by Type (2012-2017)
Table Middle East Pediatric Drugs and Vaccines Market Share by Type (2012-2017)
Figure Middle East Pediatric Drugs and Vaccines Market Share by Type (2012-2017)
Table Middle East Pediatric Drugs and Vaccines Sales (K Units) by Applications (2012-2017)
Table Middle East Pediatric Drugs and Vaccines Market Share by Applications (2012-2017)
Figure Middle East Pediatric Drugs and Vaccines Sales Market Share by Application in 2016
Table Middle East Pediatric Drugs and Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Pediatric Drugs and Vaccines Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Pediatric Drugs and Vaccines Sales Volume Market Share by Countries in 2016
Table Middle East Pediatric Drugs and Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Middle East Pediatric Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Pediatric Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Middle East Pediatric Drugs and Vaccines Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Pediatric Drugs and Vaccines Sales (K Units) by Type (2012-2017)
Table Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Sales Market Share by Type in 2016
Table Africa Pediatric Drugs and Vaccines Sales (K Units) by Application (2012-2017)
Table Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2012-2017)
Table Africa Pediatric Drugs and Vaccines Sales Volume (K Units) by Countries (2012-2017)
Table Africa Pediatric Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Sales Market Share by Countries (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Sales Market Share by Countries in 2016
Table Africa Pediatric Drugs and Vaccines Revenue (Million USD) by Countries (2012-2017)
Table Africa Pediatric Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Revenue Market Share by Countries (2012-2017)
Figure Africa Pediatric Drugs and Vaccines Revenue Market Share by Countries in 2016
Figure South Africa Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Basic Information List
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Basic Information List
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories (USA) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Basic Information List
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Amgen, Inc. (USA) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Basic Information List
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Basic Information List
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Basic Information List
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Genentech, Inc. (USA) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Basic Information List
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Basic Information List
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company) Pediatric Drugs and Vaccines Basic Information List
Table Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure Actelion Pharmaceuticals Ltd (Switzerland)(A Janssen Pharmaceutical Company) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Basic Information List
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Basic Information List
Table Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Basic Information List
Table Allergan, Inc. (USA) Pediatric Drugs and Vaccines Basic Information List
Table Novartis AG (Switzerland) Pediatric Drugs and Vaccines Basic Information List
Table Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Basic Information List
Table Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Basic Information List
Table Sanofi S.A (France) Pediatric Drugs and Vaccines Basic Information List
Table Shionogi Inc. (USA) Pediatric Drugs and Vaccines Basic Information List
Table Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pediatric Drugs and Vaccines
Figure Manufacturing Process Analysis of Pediatric Drugs and Vaccines
Figure Pediatric Drugs and Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Pediatric Drugs and Vaccines Major Manufacturers in 2016
Table Major Buyers of Pediatric Drugs and Vaccines
Table Distributors/Traders List
Figure EMEA Pediatric Drugs and Vaccines Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Pediatric Drugs and Vaccines Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Pediatric Drugs and Vaccines Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Pediatric Drugs and Vaccines Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Pediatric Drugs and Vaccines Sales Market Share Forecast by Region (2017-2022)
Table EMEA Pediatric Drugs and Vaccines Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2017-2022)
Table Europe Pediatric Drugs and Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Pediatric Drugs and Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Europe Pediatric Drugs and Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Pediatric Drugs and Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Pediatric Drugs and Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Pediatric Drugs and Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Pediatric Drugs and Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Pediatric Drugs and Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Pediatric Drugs and Vaccines Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Pediatric Drugs and Vaccines Sales Market Share Forecast by Countries (2017-2022)
Table Africa Pediatric Drugs and Vaccines Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Pediatric Drugs and Vaccines Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Pediatric Drugs and Vaccines Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2017-2022)
Table EMEA Pediatric Drugs and Vaccines Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources